Breathe
NDC 43742-1263, Argentum Nitricum, Natrum Muriaticum, Sulphur, Aconitum Napellus, Arsenicum Album, Rhus Tox, Adenosinum Cyclophosphoricum, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Lung (Suis), Mucosa Nasalis Suis, Pantothenic Acid, Sarcolacticum Acidum, Acetylcholine Chloride, Coumarinum, Malvin, Dysentery Bacillus, Proteus (Morgani), liquid, from Deseret Biologicals, Inc.
- Product NDC
- 43742-1263
- Status
- Listed
- Labeler
- Deseret Biologicals, Inc
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43742-1263 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SILVER NITRATE6 [hp_X]/mL
- SODIUM CHLORIDE6 [hp_X]/mL
- SULFUR6 [hp_X]/mL
- ACONITUM NAPELLUS8 [hp_X]/mL
- ARSENIC TRIOXIDE8 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF8 [hp_X]/mL
- ADENOSINE CYCLIC PHOSPHATE10 [hp_X]/mL
- SUS SCROFA UMBILICAL CORD10 [hp_X]/mL
- SUS SCROFA ADRENAL GLAND10 [hp_X]/mL
- SUS SCROFA LUNG10 [hp_X]/mL
- SUS SCROFA NASAL MUCOSA10 [hp_X]/mL
- PANTOTHENIC ACID10 [hp_X]/mL
- LACTIC ACID, L-10 [hp_X]/mL
- ACETYLCHOLINE CHLORIDE6 [hp_C]/mL
- COUMARIN6 [hp_C]/mL
- MALVIN15 [hp_C]/mL
- SHIGELLA DYSENTERIAE30 [hp_C]/mL
- PROTEUS MORGANII30 [hp_C]/mL
Pharmacologic classes
Cholinergic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43742-1263-1 | 43742126301 | 30 mL in 1 BOTTLE, DROPPER (43742-1263-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43742-1263 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43742-1263 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43742-1263. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.